CompWare Medical Group Expands Its Global Engagement
DULUTH, Ga., June 29, 2012 /CNW/ - Fidelitas Medical IT-Solutions, LP
announced today the launch of their product DDS, a dispensing and
documentation system for methadone treatment. Their mission, according
to the company's CEO, Andreas Kunz, is to increase the safety and
efficiency of Methadone Maintenance Treatment programs in Canada.
"Methadone is useful in the treatment of opiate dependence, but it
requires very careful, accurate and transparent handling." Mr. Kunz
says that Fidelitas can fulfill these requirements with an automated,
tamper proof, documentation and dispensing system that safely manages
and records every single mg of methadone – from the time when the
methadone arrives at the pharmacy/clinic until the stock is empty.
"Pharmacies, clinic owners, authorities, doctors and nurses can be sure
to work with a reliable system in which every action is documented
safely and accurately." Fidelitas' Vice President, Joakim Jorlander,
says, "The fear of making a mistake that could have fatal consequences
naturally creates a lot of stress. Our experience from all the fourteen
countries we are presently working in tells us that nurses and other
staff feel a lot more comfortable doing their job when the
documentation and dispensing is interactive and automated."
DDS is listed as a medical device with the U.S. Food and Drug
Administration, and the company behind it is registered as a
manufacturer of medical devices in both North America (FDA + Health
Canada) and Europe. Fidelitas' entry on the North American market has
not gone unnoticed. "The high interest is much due to our unique
integration of software and dispenser, and it also shows that MMT
programs in North America have needs that are yet to be fulfilled,"
says Fidelitas CEO, Andreas Kunz. "Our mission is to make substitution
treatment more safe, more efficient and more transparent. I believe
this will make us the best friend of patients, clinics, pharmacies and
authorities." Vice President Joakim Jorlander explains that, "this is
not just another methadone pump. We are specialists in the complete
field of substitution treatment, and this is what makes the DDS stand
out. In addition, we are positive that it will save costs for patients,
pharmacies, clinics, states, and the government."
DDS is available in Canada through "Healthmark" (www.healthmark.ca). "As one of the leading suppliers of medical and pharmacy products in
the country, Healthmark was the natural choice for us when teaming up
with a partner in Canada," says Fidelitas CEO Andreas Kunz.
Fidelitas Medical IT-Solutions, LP is the subsidiary of the well known
German company CompWare Medical, which is the worldwide leading
manufacturer of self regulating IT-based solutions in the field of OST
medicine. The CompWare Medical Group possesses extensive knowledge
after 25 years of experience in this particular field and is working
together with UN Organizations, the federal ministry of health and
other high-ranking organizations, i.e. in India and Nepal. The biggest
market is in Germany, where around 250 clinics and prisons are using
DDS. In Germany alone, the system helps to save millions of euros in
health insurances every year.
SOURCE Fidelitas Medical IT-Solutions, LP
For further information: